Document is current
Any future updates will be listed below
-
Authors
Fan, Yanni
Zhang, Ling
Omidakhsh, Negar
Bohn, Rhonda L.
Putnam, Kathleen
Adewale, A. Shola
Melmed, Gil Y.
-
Funding
Funding for this research was provided by:
Cedars-Sinai Medical Center
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 8 August 2024
First Online: 22 October 2024
Declarations
:
: YF, LZ, and ASA are employees of Boehringer Ingelheim. NO is an employee of Bohn Epidemiology and has served as a consultant to Boehringer Ingelheim. RLB is the founder of Bohn Epidemiology and has served as a consultant to Boehringer Ingelheim. KP is a consultant for Bohn Epidemiology and has no disclosures to report. GYM reports receiving grants from Pfizer; consulting fees from AbbVie, Arena, Bristol Myers Squibb, Boehringer Ingelheim, Dieta, Entasis, Ferring, Fresenius Kabi, Janssen, Lilly, Medtronic, Oshi Health, Pfizer, Samsung Bioepis, Shionogi, Takeda, TechLab, and Viatris.
: Optum is compliant with the Health Insurance Portability and Accountability Act of 1996 and does not include any patient-identifiable health information. Therefore, approval from an institutional review board was not required for this study. All patient data were anonymized and de-identified; therefore, informed consent was not necessary.
: Not applicable.
: Not applicable.
